Pharvaris (PHVS) CMO Lu Peng reports 226-share tax withholding event

Rhea-AI Filing Summary

Pharvaris N.V. Chief Medical Officer Lu Peng reported two tax-withholding dispositions tied to vesting of restricted stock units. The issuer withheld 117 and 109 common shares, totaling 226 shares, at $35.07 per share to cover tax obligations, leaving Peng with 65,405 shares held directly.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Lu Peng

Role Chief Medical Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	117	$35.07	$4K
Tax Withholding	Common Stock	109	$35.07	$4K

Holdings After Transaction: Common Stock — 65,405 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Shares withheld for taxes: 226 shares First withholding block: 117 shares Second withholding block: 109 shares +2 more

5 metrics

Shares withheld for taxes 226 shares Total common shares withheld to satisfy tax obligations upon RSU vesting

First withholding block 117 shares Common shares withheld on 2026-07-12 as part of tax-withholding disposition

Second withholding block 109 shares Common shares withheld on 2026-07-11 as part of tax-withholding disposition

Tax withholding price $35.07 per share Valuation used for both withholding transactions to satisfy tax liabilities

Shares held after transactions 65,405 shares Lu Peng’s direct Pharvaris common stock holdings following tax-withholding events

Key Terms

restricted stock units, tax withholding obligations, withheld by the issuer

3 terms

restricted stock units financial

"upon the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"to satisfy tax withholding obligations upon the vesting"

withheld by the issuer financial

"Represents shares withheld by the issuer to satisfy tax"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/14/2026 - 03:47 PM Accepted by SEC EDGAR 07/14/2026 - 03:46 PM Learn about SEC filing dates

FAQ

What insider transaction did Pharvaris (PHVS) CMO Lu Peng report?

Lu Peng reported two tax-withholding dispositions related to vesting of restricted stock units. The issuer withheld 117 and 109 Pharvaris common shares to satisfy tax obligations, rather than executing open-market sales, and Peng continues to hold a substantial direct equity position.

How many Pharvaris (PHVS) shares were withheld for Lu Peng’s taxes?

A total of 226 Pharvaris common shares were withheld to cover Lu Peng’s tax obligations. The dispositions involved blocks of 117 and 109 shares at $35.07 per share, as part of the settlement of restricted stock unit vesting.

At what price were Pharvaris (PHVS) shares valued for Lu Peng’s tax withholding?

The withheld shares were valued at $35.07 per share for tax purposes. This price applied to both the 117-share and 109-share withholding transactions, which were used to satisfy tax liabilities from restricted stock unit vesting.

How many Pharvaris (PHVS) shares does Lu Peng hold after these transactions?

After the tax-withholding dispositions, Lu Peng holds 65,405 Pharvaris common shares directly. This figure reflects the remaining ownership following the withholding of 226 shares by the issuer to satisfy tax obligations tied to restricted stock unit vesting.

Were Lu Peng’s Pharvaris (PHVS) transactions open-market sales?

No, the reported transactions were tax-withholding dispositions, not open-market sales. Pharvaris withheld 226 shares from vested restricted stock units to meet Lu Peng’s tax obligations, as described in the footnote, rather than selling shares into the market.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lu Peng

(Last) (First) (Middle)

1 CRANBERRY HILL SUITE 400

(Street)

LEXINGTON MASSACHUSETTS 02421

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Pharvaris N.V. [ PHVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/11/2026		F		109(1)	D	$35.07	65,522	D
Common Stock	07/12/2026		F		117(1)	D	$35.07	65,405	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld by the issuer to satisfy tax withholding obligations upon the vesting of restricted stock units.

	/s/ Marnus Nel, Attorney-in-Fact for Peng Lu	07/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)